PTCT:NASDAQ
PTC Therapeutics, Inc.
$63.46
arrow_downward
-1.04%(-0.67) 1D
$63.46
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 2, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa PTCT...
Buksan
$64.81
Mataas
$65.40
Mababa
$62.80
Mkt. cap
5.30B
Avg. na dami
1.09M
Dami
895.55K
Mataas nang 52-wk
$90.86
Mababa nang 52-wk
$61.23
EPS
-$0.56
Beta
0.49
Mga natitirang share
83.46M
Bilang ng mga empleyado
991
Buksan
$64.81
Mataas
$65.40
Mababa
$62.80
Mkt. cap
5.30B
Avg. na dami
1.09M
Dami
895.55K
Mataas nang 52-wk
$90.86
Mababa nang 52-wk
$61.23
EPS
-$0.56
Beta
0.49
Mga natitirang share
83.46M
Bilang ng mga empleyado
991
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketBeat
·
2 oras ang nakalipas
PTC Therapeutics (NASDAQ:PTCT) Director Sells $781,920.00 in Stock
Stock Titan
·
4 oras ang nakalipas
After exercising options at $11.23, a director sold 12,000 PTC Therapeutics (PTCT) shares at $65.16.
Stock Titan
·
2 araw ang nakalipas
A director proposes selling $782K in option-exercised PTC Therapeutics (PTCT) shares.
Profile
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Tungkol sa PTC Therapeutics, Inc.
CEOMatthew B. Klein
Mga Empleyado991
ItinatagEne 1, 1998
HeadquartersWarren, New Jersey, Estados Unidos
Sektor-
Websiteptcbio.com